Additionally, certain studies also showed that dual-inhibition of VEGF and Ang2 in glioma models prolonged survival compared with single VEGF inhibition by reprograming Tie2+ TAMs toward a pro-inflammatory/anti-tumoral phenotype (178) (Figure 3). The gene discussed is VEGFA; the disease is central nervous system cancer.